Ketolide Treatment of Haemophilus influenzae Experimental Pneumonia

The MICs of HMR 3004 and HMR 3647 at which 90% of beta-lactamase-producing Haemophilus influenzae isolates were inhibited were 4 and 2 μg/ml, respectively. Both HMR 3004 and HMR 3647 were active against beta-lactamase-producing H. influenzae in a murine model of experimental pneumonia. As assessed b...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Piper, Kerryl E., Rouse, Mark S., Steckelberg, James M., Wilson, Walter R., Patel, Robin
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1999
Aiheet:	Experimental Therapeutics
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89190/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10049297/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.3.708
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!